NasdaqGS - Nasdaq Real Time Price USD
IDEXX Laboratories, Inc. (IDXX)
509.42
+0.29
+(0.06%)
At close: May 14 at 4:00:01 PM EDT
505.91
-3.51
(-0.69%)
Pre-Market: 4:19:40 AM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 26,096 | 20 |
Sales | 14,609 | 4 |
Net Shares Purchased (Sold) | 11,487 | 24 |
Total Insider Shares Held | 538.83k | -- |
% Net Shares Purchased (Sold) | 2.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
VANDEBROEK SOPHIE V Director | Sale at price 491.34 per share. | Direct | 628,425 | May 9, 2025 |
VANDEBROEK SOPHIE V Director | Conversion of Exercise of derivative security at price 283.59 per share. | Direct | 362,712 | May 9, 2025 |
VANDEBROEK SOPHIE V Director | -- | Direct | -- | May 6, 2025 |
KINGSLEY LAWRENCE D Director | -- | Direct | -- | May 6, 2025 |
SZOSTAK MARGARET ANNE Director | -- | Direct | -- | May 6, 2025 |
JUNIUS DANIEL M Director | -- | Direct | -- | May 6, 2025 |
ESSIG STUART M Director | -- | Direct | -- | May 6, 2025 |
UNDERBERG SHARON E General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 14, 2025 |
MAZELSKY JONATHAN JAY Chief Executive Officer | -- | Direct | -- | Feb 14, 2025 |
SMITH MARTIN ALEXANDER Officer | -- | Direct | -- | Feb 14, 2025 |
LANE MICHAEL J Officer | -- | Direct | -- | Feb 14, 2025 |
HUNT NIMRATA Officer | -- | Direct | -- | Feb 14, 2025 |
JOHNSON MICHAEL PERKINS Officer | -- | Direct | -- | Feb 14, 2025 |
SCHRECK MICHAEL Officer | -- | Direct | -- | Feb 14, 2025 |
ERICKSON MICHAEL G Officer | -- | Direct | -- | Feb 14, 2025 |
UNDERBERG SHARON E General Counsel | Conversion of Exercise of derivative security at price 444.53 per share. | Direct | 60,901 | Feb 14, 2025 |
FENNELL GEORGE Officer | -- | Direct | -- | Feb 14, 2025 |
MCKEON BRIAN P Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
ERICKSON MICHAEL G Officer | Conversion of Exercise of derivative security at price 67.85 per share. | Direct | 104,760 | Feb 11, 2025 |
FENNELL GEORGE Officer | Sale at price 462.53 per share. | Direct | 4,618,862 | Feb 10, 2025 |
FENNELL GEORGE Officer | Conversion of Exercise of derivative security at price 79.54 per share. | Direct | 894,189 | Feb 10, 2025 |
SZOSTAK MARGARET ANNE Director | Sale at price 465.94 per share. | Indirect | 1,397,835 | Feb 7, 2025 |
VANDEBROEK SOPHIE V Director | Stock Gift at price 0.00 per share. | Direct | 0 | Nov 27, 2024 |
VANDEBROEK SOPHIE V Director | Sale at price 420.44 per share. | Direct | 144,630 | Nov 27, 2024 |
AYERS JONATHAN W Director | Stock Gift at price 0.00 per share. | Indirect | 0 | Sep 6, 2024 |
SZOSTAK MARGARET ANNE Director | Sale at price 469.37 per share. | Indirect | 234,686 | Sep 6, 2024 |
SZOSTAK MARGARET ANNE Director | Stock Gift at price 0.00 per share. | Indirect | 0 | Sep 5, 2024 |
SMITH MARTIN ALEXANDER Officer | -- | Direct | -- | Aug 30, 2024 |
SCHRECK MICHAEL Officer | -- | Direct | -- | Aug 30, 2024 |
MAZELSKY JONATHAN JAY Chief Executive Officer | -- | Direct | -- | Aug 5, 2024 |
MCKEON BRIAN P Chief Financial Officer | -- | Direct | -- | Aug 5, 2024 |
CLAFLIN BRUCE L Director | Sale at price 540.80 per share. | Direct | 108,160 | May 17, 2024 |
CLAFLIN BRUCE L Director | Sale at price 540.80 per share. | Direct | 108,160 | May 17, 2024 |
SZOSTAK MARGARET ANNE Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 8, 2024 |
COLLINS ASHA S. Director | -- | Direct | -- | May 6, 2024 |
BRITT IRENE CHANG Director | -- | Direct | -- | May 6, 2024 |
VANDEBROEK SOPHIE V Director | -- | Direct | -- | May 6, 2024 |
KINGSLEY LAWRENCE D Director | -- | Direct | -- | May 6, 2024 |
AYERS JONATHAN W Director | -- | Direct | -- | May 6, 2024 |
SZOSTAK MARGARET ANNE Director | -- | Direct | -- | May 6, 2024 |
ESSIG STUART M Director | -- | Direct | -- | May 6, 2024 |
POLEWACZYK JAMES F Officer | Sale at price 557.94 - 559.33 per share. | Direct | 4,525,596 | Mar 6, 2024 |
POLEWACZYK JAMES F Officer | Conversion of Exercise of derivative security at price 206.94 - 544.08 per share. | Direct | 3,423,547 | Mar 6, 2024 |
VANDEBROEK SOPHIE V Director | Sale at price 562.98 per share. | Direct | 790,427 | Mar 5, 2024 |
VANDEBROEK SOPHIE V Director | Conversion of Exercise of derivative security at price 245.79 per share. | Direct | 345,089 | Mar 5, 2024 |
MAZELSKY JONATHAN JAY Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
MAZELSKY JONATHAN JAY Chief Executive Officer | Conversion of Exercise of derivative security at price 206.94 per share. | Direct | 99,952 | Feb 21, 2024 |
UNDERBERG SHARON E General Counsel | Conversion of Exercise of derivative security at price 206.94 per share. | Direct | 99,952 | Feb 16, 2024 |
MCKEON BRIAN P Chief Financial Officer | Conversion of Exercise of derivative security at price 206.94 per share. | Direct | 99,952 | Feb 15, 2024 |
UNDERBERG SHARON E General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 14, 2024 |
Related Tickers
MTD Mettler-Toledo International Inc.
1,117.81
-5.03%
MEDP Medpace Holdings, Inc.
291.73
-5.94%
DHR Danaher Corporation
187.82
-4.47%
TMO Thermo Fisher Scientific Inc.
406.05
-5.34%
WAT Waters Corporation
345.38
-3.80%
IQV IQVIA Holdings Inc.
141.82
-5.88%
A Agilent Technologies, Inc.
111.52
-3.38%
CRL Charles River Laboratories International, Inc.
138.95
-3.52%
ICLR ICON Public Limited Company
132.23
-5.88%
ILMN Illumina, Inc.
78.21
-2.60%